Literature DB >> 26786109

Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins.

Tom Ronan1, Jennifer L Macdonald-Obermann2, Lorel Huelsmann2, Nicholas J Bessman3, Kristen M Naegle4, Linda J Pike5.   

Abstract

The EGF receptor can bind seven different agonist ligands. Although each agonist appears to stimulate the same suite of downstream signaling proteins, different agonists are capable of inducing distinct responses in the same cell. To determine the basis for these differences, we used luciferase fragment complementation imaging to monitor the recruitment of Cbl, CrkL, Gab1, Grb2, PI3K, p52 Shc, p66 Shc, and Shp2 to the EGF receptor when stimulated by the seven EGF receptor ligands. Recruitment of all eight proteins was rapid, dose-dependent, and inhibited by erlotinib and lapatinib, although to differing extents. Comparison of the time course of recruitment of the eight proteins in response to a fixed concentration of each growth factor revealed differences among the growth factors that could contribute to their differing biological effects. Principal component analysis of the resulting data set confirmed that the recruitment of these proteins differed between agonists and also between different doses of the same agonist. Ensemble clustering of the overall response to the different growth factors suggests that these EGF receptor ligands fall into two major groups as follows: (i) EGF, amphiregulin, and EPR; and (ii) betacellulin, TGFα, and epigen. Heparin-binding EGF is distantly related to both clusters. Our data identify differences in network utilization by different EGF receptor agonists and highlight the need to characterize network interactions under conditions other than high dose EGF.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer biology; epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); growth factor; receptor tyrosine kinase; systems biology

Mesh:

Substances:

Year:  2016        PMID: 26786109      PMCID: PMC4786695          DOI: 10.1074/jbc.M115.710087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  EGFR signaling patterns are regulated by its different ligands.

Authors:  Stine Louise Jeppe Knudsen; Anni Sieu Wai Mac; Lasse Henriksen; Bo van Deurs; Lene Melsæther Grøvdal
Journal:  Growth Factors       Date:  2014-10       Impact factor: 2.511

Review 2.  EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.

Authors:  Kristy J Wilson; Christopher Mill; Sydney Lambert; Jennifer Buchman; Timothy R Wilson; Victor Hernandez-Gordillo; Richard M Gallo; Laura M C Ades; Jeffrey Settleman; David J Riese
Journal:  Growth Factors       Date:  2012-01-20       Impact factor: 2.511

3.  Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.

Authors:  Jennifer L Macdonald-Obermann; Sangeeta Adak; Ralf Landgraf; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

4.  Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.

Authors:  Andrew H A Clayton; Francesca Walker; Suzanne G Orchard; Christine Henderson; Dominik Fuchs; Julie Rothacker; Edouard C Nice; Antony W Burgess
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

5.  An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.

Authors:  Xuewu Zhang; Jodi Gureasko; Kui Shen; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

Review 6.  Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis.

Authors:  Weiye Wang; Suowen Xu; Meimei Yin; Zheng Gen Jin
Journal:  Int J Cardiol       Date:  2014-10-24       Impact factor: 4.164

7.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

8.  Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.

Authors:  Jennifer L Macdonald-Obermann; Linda J Pike
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

9.  MARQUIS: a multiplex method for absolute quantification of peptides and posttranslational modifications.

Authors:  Timothy G Curran; Yi Zhang; Daniel J Ma; Jann N Sarkaria; Forest M White
Journal:  Nat Commun       Date:  2015-01-12       Impact factor: 14.919

10.  Temporal regulation of EGF signalling networks by the scaffold protein Shc1.

Authors:  Yong Zheng; Cunjie Zhang; David R Croucher; Mohamed A Soliman; Nicole St-Denis; Adrian Pasculescu; Lorne Taylor; Stephen A Tate; W Rod Hardy; Karen Colwill; Anna Yue Dai; Rick Bagshaw; James W Dennis; Anne-Claude Gingras; Roger J Daly; Tony Pawson
Journal:  Nature       Date:  2013-07-11       Impact factor: 49.962

View more
  20 in total

1.  Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.

Authors:  Dominic Devost; Rory Sleno; Darlaine Pétrin; Alice Zhang; Yuji Shinjo; Rakan Okde; Junken Aoki; Asuka Inoue; Terence E Hébert
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

2.  Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.

Authors:  Rui Chen; Ge Jin; Wei Li; Thomas M McIntyre
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

3.  A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.

Authors:  William D Shipman; Susan Chyou; Anusha Ramanathan; Peter M Izmirly; Sneh Sharma; Tania Pannellini; Dragos C Dasoveanu; Xiaoping Qing; Cynthia M Magro; Richard D Granstein; Michelle A Lowes; Eric G Pamer; Daniel H Kaplan; Jane E Salmon; Babak J Mehrara; James W Young; Robert M Clancy; Carl P Blobel; Theresa T Lu
Journal:  Sci Transl Med       Date:  2018-08-15       Impact factor: 17.956

Review 4.  Interrogating Cellular Communication in Cancer with Genetically Encoded Imaging Reporters.

Authors:  Seth T Gammon; Tracy W Liu; David Piwnica-Worms
Journal:  Radiol Imaging Cancer       Date:  2020-07-31

5.  Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.

Authors:  Kamaldeep Gill; Jennifer L Macdonald-Obermann; Linda J Pike
Journal:  J Biol Chem       Date:  2017-10-26       Impact factor: 5.157

Review 6.  Receptor tyrosine kinase activation: From the ligand perspective.

Authors:  Raphael Trenker; Natalia Jura
Journal:  Curr Opin Cell Biol       Date:  2020-02-27       Impact factor: 8.382

7.  EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.

Authors:  Daniel M Freed; Nicholas J Bessman; Anatoly Kiyatkin; Emanuel Salazar-Cavazos; Patrick O Byrne; Jason O Moore; Christopher C Valley; Kathryn M Ferguson; Daniel J Leahy; Diane S Lidke; Mark A Lemmon
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

Review 8.  EGF receptor ligands: recent advances.

Authors:  Bhuminder Singh; Graham Carpenter; Robert J Coffey
Journal:  F1000Res       Date:  2016-09-08

Review 9.  Ligand bias in receptor tyrosine kinase signaling.

Authors:  Kelly Karl; Michael D Paul; Elena B Pasquale; Kalina Hristova
Journal:  J Biol Chem       Date:  2020-10-29       Impact factor: 5.157

10.  Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.

Authors:  Jian Gao; Camilla H Ulekleiv; Trond S Halstensen
Journal:  J Exp Clin Cancer Res       Date:  2016-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.